1 Min Read
May 15 (Reuters) - MOLOGEN AG
* RECRUITMENT GOAL ACHIEVED FOR PIVOTAL IMPALA STUDY WITH LEFITOLIMOD IN COLORECTAL CANCER PATIENTS Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.